Zyla Life Sciences Financing Cash Flow
Zyla Life Sciences reported Financing Cash Flow of -$2.81 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2020-05-14
- Zyla Life Sciences net cash provided by (used in) financing activities for the quarter ending 2020-03-31 was -$2.81M.
- Zyla Life Sciences net cash provided by (used in) financing activities for the quarter ending 2018-12-31 was -$883.00K.
- Zyla Life Sciences net cash provided by (used in) financing activities for the quarter ending 2018-09-30 was -$52.00K, a 100.18% decline year-over-year.
- Zyla Life Sciences net cash provided by (used in) financing activities for the quarter ending 2018-06-30 was $891.00K, a 68.20% decline year-over-year.
- Zyla Life Sciences net cash provided by (used in) financing activities for fiscal 2018 was $3.91M, a 94.36% decline from fiscal 2017.
- Zyla Life Sciences net cash provided by (used in) financing activities for fiscal 2017 was $69.35M, a 220.38% increase from fiscal 2016.
- Zyla Life Sciences net cash provided by (used in) financing activities for fiscal 2016 was $21.65M, a 85.79% decline from fiscal 2015.
- Zyla Life Sciences net cash provided by (used in) financing activities for fiscal 2015 was $152.29M.
| Period end | Net Cash Provided by (Used in) Financing Activities 1 month | Net Cash Provided by (Used in) Financing Activities 2 month | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 5 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 8 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 11 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | -$2.81M 10-Q · filed 2020-05-14 | ||||||||
| 2019-12-31 | $914.00K 10-K · filed 2020-03-26 | ||||||||
| 2019-09-30 | $3.54M 10-Q · filed 2019-11-14 | ||||||||
| 2019-06-30 | $3.85M 10-Q · filed 2019-08-13 | ||||||||
| 2019-03-31 | $4.78M 10-Q · filed 2020-05-14 | ||||||||
| 2019-01-31 | -$19.10M 10-Q · filed 2020-05-14 | ||||||||
| 2018-12-31 | -$883.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$935.00K derived: sum of 2 quarters · filed 2020-03-26 | -$44.00K derived: sum of 3 quarters · filed 2020-03-26 | $3.91M 10-K · filed 2020-03-26 | |||||
| 2018-09-30 | -$52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $839.00K derived: sum of 2 quarters · filed 2019-11-14 | $4.79M 10-Q · filed 2019-11-14 | $3.65M derived: sum of 4 quarters · filed 2019-11-14 | |||||
| 2018-06-30 | $891.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $4.85M 10-Q · filed 2018-08-09 | $3.70M derived: sum of 3 quarters · filed 2019-03-29 | $32.23M derived: sum of 4 quarters · filed 2019-03-29 | |||||
| 2018-03-31 | $3.96M 10-Q · filed 2018-05-10 | $2.81M derived: sum of 2 quarters · filed 2019-03-29 | $31.34M derived: sum of 3 quarters · filed 2019-03-29 | $34.14M derived: sum of 4 quarters · filed 2019-03-29 | |||||
| 2017-12-31 | -$1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $27.39M derived: sum of 2 quarters · filed 2019-03-29 | $30.19M derived: sum of 3 quarters · filed 2019-03-29 | $69.35M 10-K · filed 2019-03-29 | |||||
| 2017-09-30 | $28.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-19 | $31.34M derived: sum of 2 quarters · filed 2018-11-19 | $70.50M 10-Q · filed 2018-11-19 | $70.50M derived: sum of 4 quarters · filed 2018-11-19 | |||||
| 2017-06-30 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $41.97M 10-Q · filed 2018-08-09 | $41.97M derived: sum of 3 quarters · filed 2018-08-09 | $63.46M derived: sum of 4 quarters · filed 2018-08-09 | |||||
| 2017-03-31 | $39.16M 10-Q · filed 2018-05-10 | $39.16M derived: sum of 2 quarters · filed 2018-05-10 | $60.66M derived: sum of 3 quarters · filed 2018-05-10 | ||||||
| 2016-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $21.49M derived: sum of 2 quarters · filed 2018-03-16 | $21.65M 10-K · filed 2018-03-16 | ||||||
| 2016-09-30 | $21.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $21.65M 10-Q · filed 2017-11-08 | |||||||
| 2016-06-30 | $155.00K 10-Q · filed 2017-08-09 | ||||||||
| 2015-12-31 | $152.29M 10-K · filed 2018-03-16 |